Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorImagine Institute

About this trial

Over the past twenty years, Prof. Yanick Crow and his team have developed internationally recognized expertise in genetic pathologies affecting the immune and neurological systems. The pathologies studied have a particularly severe impact on patients' quality of life, with a high mortality rate and a significant risk of occurrence in affected families. These pathologies are rare, and very often under-diagnosed. To date, there is virtually no effective curative treatment.

Prof. Crow's team operates at the frontier between clinical and research work, and from experience, the team knows that patients and families affected by these serious pathologies are often highly motivated to help research into the pathology that affects them.

Initially, Prof. Crow's research focused primarily on the study of the genetic disease Aicardi-Goutières Syndrome (AGS). However, there is an undeniable clinical and pathological overlap between AGS and other forms of disease such as autoimmune systemic lupus erythematosus and many other genetic pathologies - e.g. familial lupus engelure, spondyloenchondromatosis and COPA syndrome. This is why research is being extended to all genetic diseases with immune and neurological dysfunctions.

Eligibility criteria

Qualifiers

Have / present a family history of genetic disease with immune and neurological dysfunction.

Have signed an informed consent form.

Be related to a patient included in this research.

Have signed an informed consent form.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Biological Samples

Treatment groups

1,000 Participants
are divided into 3 treatment groups

Sponsors and collaborators